Physician

Aalok Vilas Malankar, D.O.

According to 2025 Medicare claims, Aalok Malankar, D.O. (NPI: 1124265087) practices family practice in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Baltimore City, MD. This provider's primary affiliated billing organization is CHASE BREXTON HEALTH SERVICES, INC. (NPI: 1588606305; TIN: 521638592) and primary practice location at 21244-2412. Malankar is affiliated with the Aledade 200 Chesapeake MSSP Enhanced (ACO ID: A5365), participating under the MSSP model.

Malankar's data goes back to 2015 and runs through 2024. For example, in 2022, this provider had 211 traditional Medicare patients, billed 940 HCPCS/CPT codes, and received $46,855 in Medicare payments. 2024 Part D data shows 2,142 prescription claims across 172 beneficiaries totaling $273,849 in drug costs, led by Ozempic (Semaglutide). 2024 DME data shows 50 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $58,702 and ending at $46,855. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $461,216 and ending at $273,849. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $10,556 to $5,442.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	299	1,036	$58,702
2016	294	1,049	$57,706
2017	306	1,208	$63,294
2018	364	1,456	$79,955
2019	339	1,472	$79,520
2020	259	948	$51,320
2021	327	1,177	$67,205
2022	211	940	$46,855
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	555	7,462	$461,216
2016	544	7,972	$525,046
2017	634	9,733	$664,265
2018	615	8,423	$616,396
2019	546	6,414	$486,876
2020	499	5,656	$492,423
2021	517	6,634	$701,501
2022	534	6,911	$845,581
2023	386	2,113	$270,478
2024	172	2,142	$273,849

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	46	293	$13,072
2016	45	242	$6,559
2017	41	188	$2,701
2018	38	197	$4,847
2019	11	134	$3,638
2020	N/R	163	$3,682
2021	12	144	$2,699
2022	15	140	$2,982
2023	N/R	69	$1,916
2024	N/R	50	$5,479

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	54	1,988	$54,097
Jardiance	Empagliflozin	30	2,440	$46,209
Eliquis	Apixaban	31	1,050	$20,376
Januvia	Sitagliptin Phosphate	14	1,050	$19,275
Farxiga	Dapagliflozin Propanediol	16	790	$15,433

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$3,914
J7515	Cyclosporine, oral, 25 mg	N	N/R	11	$1,191
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$188
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$185

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Aalok Vilas Malankar, D.O.?

Tedicare shows public-source Medicare data for Aalok Vilas Malankar, D.O. (NPI 1124265087), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aalok Vilas Malankar, D.O. have ACO affiliation data?

Aalok Vilas Malankar, D.O. is shown with ACO affiliation data for Aledade 200 Chesapeake MSSP Enhanced (MSSP, ACO ID A5365).

What billing organization is linked to Aalok Vilas Malankar, D.O.?

Aalok Vilas Malankar, D.O. is linked to CHASE BREXTON HEALTH SERVICES, INC. (billing NPI 1588606305) in the available physician profile data.

Does Aalok Vilas Malankar, D.O. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.